Power

John Roberts Cares About His Reputation—Not Abortion Rights

Imani Gandy

The chief justice of the Supreme Court helped deliver a win for abortion rights in June Medical Services v. Russo. Don't trust it.

How Congress Can Immediately Seize on Monday’s Abortion Rights Win

Dr. Herminia Palacio

The Women's Health Protection Act would protect abortion access from bans and burdensome restrictions.

How to Find a Gender-Affirming Doctor

Jamie J. LeClaire

For transgender and nonbinary people, a gender-affirming doctor—a patient-centered provider who is aware, sensitive, and educated on the needs of the transgender community—can be crucial to our survival.

Will This Supreme Court Term Ever End?

Jessica Mason Pieklo

Supreme Court decision days have become another spectacle during the Trump years.

How Queer Writers and Activists Are Dismantling What’s ‘Normal’

Sarah Neilson

This Pride, Rewire.News interviewed queer authors Alok Vaid-Menon, Kimberly Drew, and Adam Eli on what it means to "dream more boldly" about the future of queer liberation.

States Get Sneaky With Latest Abortion Restrictions

Imani Gandy

Efforts to make getting an abortion a pain in the ass continue unabated in states like Colorado, Iowa, Michigan, Mississippi, and Tennessee.

On TikTok, Gen Z Takes on Trump—and Abortion Lies

Paige Alexandria

Young people on TikTok are creating videos to offer a glimpse of their struggles and opinions with videos that discuss abortion, mental illness, or their political beliefs.

Trump’s 200th Judge Will Mean Decades of Fighting for Our Rights

Lisa Needham

It took President Donald Trump less than four years to take over the federal courts. It will take us a lifetime to undo the damage.

Explaining Black Motherhood to a White Mom—and to Myself

Kai McGee

A casual conversation at a food bank turned into something frustrating—and fruitful.

If the Government Cared About HIV, PrEP Would Be Free

Tim Forster

If you had the power to potentially stop the HIV epidemic in its tracks, would you use it? Not if you’re the U.S. government—or a multibillion-dollar pharmaceutical giant.